|
Prescription Drug Search
Strengths available for Doryx:
Browse Alphabetically:
A
·
B
·
C
·
D
·
E
·
F
·
G
·
H
·
I
·
J
·
K
·
L
·
M
·
N
O
·
P
·
Q
·
R
·
S
·
T
·
U
·
V
·
W
·
X
·
Y
·
Z
·
#
Information about MyGlobalPharmacy.com
List of countries where we can ship Doryx:
- Albania
- Antigua and Barbuda
- Argentina
- Australia
- Bahamas
- Barbados
- Belgium
- Colombia
- Cyprus
- Czech Republic
- Estonia
- European Union
- Fiji
- Georgia
- Greenland
- Guam
- Guatemala
- Hong Kong
- India
- Indonesia
- Iran
- Jamaica
- Korea, South
- Lebanon
- Liechtenstein
- Malta
- Moldova, Republic of
- Monaco
- Netherlands Antilles
- Paraguay
- Romania
- South Africa
- Sri Lanka
- Switzerland
- Tunisia
- United Kingdom, UK
- United States, US
- Uruguay
- Vietnam
- Yemen
Latest news releases on Doryx:
Mylan Raises 2012 Earnings Guidance - Analyst Blog - NASDAQ
Last week, Mylan had announced that it has launched the first generic equivalent of Mayne Pharma's Doryx (150 mg), which is marketed by Warner Chilcott ( WCRX). The U.S. District Court for the District of New Jersey ruled against the patent ...
Mylan Raises 2012 Earnings Guidance - Yahoo Finance
Last week, Mylan had announced that it has launched the first generic equivalent of Mayne Pharma's Doryx (150 mg), which is marketed by Warner Chilcott (WCRX). The U.S. District Court for the District of New Jersey ruled against the patent ...
Watson files for low-dose birth control generic - Marketwatch
Mylan Inc. (MYL) this month launched a generic version of its Doryx acne drug after winning the approval of a federal court weighing in on a dispute between the two companies. Shares of Warner Chilcott were recently off 16 cents to $20.01.
Warner Chilcott Tops But Cuts View - Analyst Blog - NASDAQ
Moreover, reduced sales of dermatological product Doryx also hurt revenues in the reported quarter. Revenues, however, beat the Zacks Consensus Estimate of $651 million. Revenues from osteoporosis products declined 30.5% to $162 million.
Mylan ups earnings view, plans $500 mln buyback - Marketwatch
Mylan recently said it launched the first generic version of its Doryx acne drug, swiftly moving it to market after winning approval from a federal court weighing in on the company's patent dispute with Ireland-based drug maker Warner Chilcott ...
